Glez Pharmaceuticals Private Limited

Glez Pharmaceuticals Private Limited - business services in Gwalior, Madhya Pradesh, India. Directors, charges & compliance details.
CIN U51100MP2020PTC051229 Incorporated 30 March 2020 ROC Gwalior HQ Gwalior, Madhya Pradesh, India
Active Private Limited Company business services MSME · Micro
Revenue · FY 2022
₹9.23 Lakh
▲ 18% YoY
Net loss · FY 2022
₹16,407
Net margin -1.8%
EBITDA · FY 2022
₹12,638
EBITDA margin 1.4%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹2 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered

About Glez Pharmaceuticals Private Limited

Data last updated:

Glez Pharmaceuticals Private Limited is a private limited company based in Gwalior, Madhya Pradesh, India. It operates in the wholesale trading and distribution segment of the business services sector. It was incorporated on 30 March 2020 and has been in existence for over 6 years.

The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U51100MP2020PTC051229. Its GSTIN is 23AAICG2785M1Z7 (Madhya Pradesh).

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors Ved Prakash Jha (Managing Director) and Tejaswini Patil (Whole-Time Director).

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at N/4 Govardhan Apartment 24 Beegha Vinay Nagar Lashkar, Gwalior, Madhya Pradesh, India – 474012.

As per the financials filed for FY 2022, the company reported a revenue of ₹9.23 Lakh, a growth of 18% compared to the previous year. For the same year it recorded a net loss of ₹16,407 (net margin -1.8%) and EBITDA of ₹12,638 (EBITDA margin 1.4%).

Glez Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MP-20-0030512).

Company details

CIN U51100MP2020PTC051229
Registration Number 051229
Incorporation Date 30 March 2020
ROC Gwalior
Listing Status Unlisted
Company Status Active
MSME Classification Micro
Udyam Registration UDYAM-MP-20-0030512

Recognitions & Rankings of Glez Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Micro (2023-24)
Udyam number
UDYAM-MP-20-0030512

Contact details

Glez Pharmaceuticals Private Limited's registered office is in Gwalior, Madhya Pradesh.

  • Registered Address
    N/4 Govardhan Apartment 24 Beegha Vinay Nagar Lashkar, Gwalior, Madhya Pradesh, India – 474012
  • Industry
    Business Services, Wholesale, Contractual Work
Comprehensive company report
Glez Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Glez Pharmaceuticals is hospital and medical care. In detail, this covers other hospital and medical care activities.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
QHospital and Medical CareQ6Other Hospital and Medical Care Activities

To see the full business activity and turnover split of Glez Pharmaceuticals Private Limited, buy the company report.

Financials of Glez Pharmaceuticals Private Limited

FY 2025 filings available

Glez Pharmaceuticals Private Limited reported revenue of ₹9.23 Lakh (up 18% YoY) for FY 2022.

Revenue · FY 2022
₹9.23 Lakh ▲ 18%
Net loss · FY 2022
₹16,407 margin -1.8%
EBITDA · FY 2022
₹12,638 margin 1.4%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 18%
EBITDA CAGR growth
1 year
▲ 170%

Revenue rose 18% in the latest year. EBITDA rose 170% in the latest year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹12,638
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹16,407
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin1.4%
Net Profit Margin-1.8%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Glez Pharmaceuticals Private Limited, buy the company report.

Board of directors of Glez Pharmaceuticals Private Limited

Glez Pharmaceuticals has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Ved Prakash JhaManaging Director30 Mar 20206 Years 7 MonthsCurrent
Tejaswini PatilWhole-Time Director30 Mar 20206 Years 7 MonthsCurrent

MSME payment delays

No delayed payments to MSME suppliers are on our record for Glez Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Glez Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
23AAICG2785M1Z7Madhya PradeshActive24 Jun 2020

To see the full GST registrations and return filing status of Glez Pharmaceuticals Private Limited, buy the company report.

Recent activity

Glez Pharmaceuticals Private Limited has 2 board changes on record since 2020: 2 appointments. The latest: Tejaswini Patil was appointed as Whole-Time Director on 30 Mar 2020.

AGM
Glez Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Glez Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Gwalior.
Appointed
Tejaswini Patil was appointed as Whole-Time Director.
Appointed
Ved Prakash Jha was appointed as Managing Director.
Incorporation
30 Mar 2020
Glez Pharmaceuticals Private Limited was registered on 30 Mar 2020 with Roc Gwalior & aged 6 years 7 months as per MCA records.

Frequently asked questions

Glez Pharmaceuticals is an active private limited company based in Gwalior, Madhya Pradesh, India. The company works in wholesale, within the business services industry. It was incorporated on 30 March 2020 (6+ years old) and is registered under CIN U51100MP2020PTC051229.

Glez Pharmaceuticals has 2 current directors:

The latest financial statements of Glez Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.

The GSTIN of Glez Pharmaceuticals is 23AAICG2785M1Z7, registered in Madhya Pradesh.

The CIN (Corporate Identification Number) of Glez Pharmaceuticals is U51100MP2020PTC051229. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Glez Pharmaceuticals was incorporated on 30 March 2020, making it 6+ years old. It is registered with the Registrar of Companies, Gwalior.

Tejaswini Patil was appointed as Whole-Time Director on 30 Mar 2020. Ved Prakash Jha was appointed as Managing Director on 30 Mar 2020.

Yes, Glez Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MP-20-0030512).

The registered office of Glez Pharmaceuticals is at N4 Govardhan Apartment 24 Beegha Vinay Nagar Lashkar, Gwalior, Madhya Pradesh, India – 474012.

Glez Pharmaceuticals operates in the business services industry, in the wholesale segment.